Zeposia (Ozanimod): A Selective S1P Receptor Modulator for MS

By Dr. Emily Hanover

Zeposia (Ozanimod): A Selective S1P Receptor Modulator for MS is an in-depth exploration of one of the latest advancements in multiple sclerosis (MS) treatment. Written by Dr. Emily Hanover, this book provides a comprehensive overview of Zeposia (Ozanimod), a selective sphingosine-1-phosphate (S1P) receptor modulator, detailing its pharmacology, clinical efficacy, safety profile, and role in disease management.

This book is designed for healthcare professionals, researchers, and patients seeking a deeper understanding of MS treatment strategies. It covers the history of Zeposia's development, its mechanism of action in modulating immune cell retention, and how it compares to other disease-modifying therapies. The discussion extends to clinical trial data, dosing guidelines, special considerations for patient populations, and emerging trends in MS therapy.

With a clear and informative approach, Zeposia (Ozanimod): A Selective S1P Receptor Modulator for MS serves as a valuable resource for those looking to stay updated on the latest developments in MS treatment and the evolving landscape of S1P receptor modulation.

• Format: Paperback
• Language: English
• ISBN: B0F1G87DC9
• ISBN13: 9798314069356
• Release Date: March 2025
• Publisher: Independently Published
• Length: 198 Pages
• Weight: 0.60 lbs.
• Dimensions: 0.4" x 6.0" x 9.0"